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We analysed the efficacy of pleural adenosine deaminase (ADA,) and the ADA1/ADA, ratio in the diagnosis of 
pleural tuberculosis in 103 pleural effusions, 27 of which were tuberculosis (TB) and 76 other diagnoses (non-TB). 
Smears, cultures and pleural biopsies were carried out in all cases, and were used for final diagnosis. 
The diagnostic yield of the parameters under study were as follows: smears/cultures of mycobacteria in fluid 
11.1%/33.3%; biopsy 33.3%/51.8% and tuberculosis granulomas 85.1%. The levels of ADA, and ADA1/ADA, 
ratio in TB and non-TB groups showed very significant differences (P<O.OOOOl); in the TB group: ADA, 
54.7f23.5 IU and ADA1/ADA, 0.27$-0.08; in the non-TB group: ADA, 18.3k43.2 IU and ADA1/ADA, 
0.64kO.14. 
The assay established ADA levels in pleural fluid 2 40 IU and an ADAl/ADA, ratio 5 0.42 as cut-off levels to 
identify individuals in the TB group, with a sensitivity of 88~8%/100%, a specificity of 92%/98.6%, a positive 
predictive value (PPV) of 80%/96.4%, a negative predictive value (NPV) of 95.8%/100% and an accuracy of 
91.2%/99.02%. 
The ADA, levels in 27 patients with TB, showed close correlation with the number of monocyte macrophages 
(P= O.OOl), but not with the number of lymphocytes (P=n.s.). 
The ADA1/ADA, ratio overcomes the limitations of ADA, (false positives and negatives), and is the most useful 
parameter for diagnosis on account of a high diagnostic yield, low cost and speed of the asssay for identifying a 
pleural tuberculosis diagnosis, when compared with traditional methods. 
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Introduction 
The low sensitivity and speed of conventional methods for 
diagnosis of tuberculosis in pleural fluid, urges a need to 
establish alternative criteria for diagnosis through the 
presence of necrotic caseous granulomas in tests obtained 
by biopsy (> 85%)(1-5). Hence, it is necessary to search for 
parameters in pleural fluid that will correct these deficien- 
cies (3,616). 
ADA, (total pleura ADA level) is an enzyme which is 
typically found at high concentrations in pleural tubercu- 
losis, with high levels of sensitivity (Sl-100%) and 
specificity (83-100%) (9,16,17). However, with the presence 
of false positives, especially in empyemas, lymphomas and 
malignant neoplasia, it is often considered a more useful 
parameter for excluding, rather than confirming, the 
diagnosis of pleural tuberculosis (TB) (6,18-20). This 
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controversy arises from an inadequate interpretation of 
the ADAp values and isoenzymes (ADA1 and ADA2) and 
their origin and significance (21). 
ADA catalyzes the deamination of adenosine and 
deoxyadenosine, into inosine and deoxyinosine, respectively 
(22,23). Two isoenzymes coded for at different gene loci 
exist, ADAl and ADA2, both having different optimal pH, 
Michaelis constant and relative substrate specificity pat- 
terns (21-25). The ADAl isoenzyme shows equal affinity 
for adenosine and 2-deoxyadenosine, with a 2-deoxyade- 
nosine/ADA, activity ratio of approx. 0.75. The isoenzyme 
is found in all cells, but has greatest activity in lymphocytes 
and monocytes (21-25). ADA2 on the other hand, has a 
poor affinity for 2-deoxyadenosine, with the 2-deoxyade- 
nosine/ADA activity ratio reaching approx. 0.25. ADA2 is 
found only in monocytes and not in other cells (21,25,26). 
This explains why ADA2 increases in biological fluids in the 
course of infectious diseases characterized by micro- 
organisms infecting the macrophages. Therefore, it is very 
important to establish whether high ADAp activity in 
pleural fluid is due mainly to the presence of ADA1 or 
ADA2. The phagocytosis of the tuberculosis mycobacte- 
rium by monocytic cells may lead to these cells being 
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responsible for the increase in ADA activity observed in 
pleural tuberculosis, as a result of a rise in ADAz, expressed 
by low levels of ADAJADA, ratio in pleural fluid (21). 
With these criteria, we analysed prospectively the level of 
ADA, and the ADAJADA, ratio in pleural fluid, and 
compared the yield from both parameters for the diagnosis 
of TB in 103 patients with pleural effusions. The correla- 
tions between ADA, level in pleural fluid and the number 
(%) of lymphocytes and monocytes in the same fluid from 
TB and non-TB groups, were also analysed. 
Material and method 
One hundred and three thoracentesis from 98 patients with 
pleural effusion were studied. The diagnostic criteria used 
were as follows (1,27); heart failure: compatible clinical and 
radiological findings, response to appropriate treatment 
and absence of other diagnosis; ascitic trasudate: associated 
pleural effusion in patients with portal hypertension and 
response to diuretic treatment; malignant neoplasia: pre- 
sence of malignant cytological and/or histological biopsy; 
paramalignant neoplasia: exudate without malignant evi- 
dence although associated with synchronous malignant 
disease; tuberculosis: positive smears/cultures in fluid or 
pleural biopsy, or necrotic caseous granulomas in biopsy 
tissue; parapneumonic: exudate associated with pneumonia 
or abscess; empyema: purulent exudate or positive culture 
in exudate; idiopathic: pleural effusion with unknown 
aetiology after performing two thoracentesis with pleural 
biopsy and spontaneous regression, or if persistent with 
thoracoscopy or thoracotomy; other diagnoses (pulmonary 
embolism and collagen vascular disease) were confirmed 
with complimentary studies. 
Light’s criteria (1) were used to discriminate between 
exudates and transudates. All cases were prospectively 
studied. The parameters analysed in pleural fluid were: pH, 
counter cells and cytological and microbiological studies 
(smears and culture for bacteria and mycobacteria). In both 
pleura and blood the following parameters were considered: 
protein, lactate dehydrogenase (LDH): glucose, cholesterol, 
triglycerides, ADA,; ADAi and ADAJADA, pleural ratio. 
The ADA, level was determined by the Blake-Berman 
method (23,28), and ADAi by the CarilaossGakis method. 
Pleural biopsies were taken in all cases with suspected 
malignant or granulomatosis diseases, or unknown exu- 
dates. Blind pleural biopsies were realized and five speci- 
mens were taken: four for histological analyses and one for 
smear and culture. The diagnosis was confirmed by studies 
in fluid, blind pleural biopsy, thoracoscopy, thoracotomy 
and clinical radiological evaluation. 
The statistical analyses applied were: frequency distribu- 
tion, the x2 test with Fisher’s or Yates correction, to analyse 
the dependence between qualitative variables, the non- 
parametric Mann-Whitney U-test, for continuous variables 
with non-normal distribution and Student’s r-test for those 
with normal distribution. Distributions were considered 
normal or non-normal as defined by the Saphiro-Wilks 
test. 
Analysis of correlation between qualitative variables was 
calculated using the Spearman rank correlation coefficient. 
For some variables it was necessary to transform the figures 
into more manageable quantities in order to reduce the 
variance about the mean distribution. All yields of the 
parameters studied were assessed in terms of sensitivity, 
specificity, positive predictive-value (PPV), negative pre- 
dictive value (NPV) and efficacy or accuracy. 
Of the 103 thoracentesis studied 69 (66.9%) were carried 
out in men and 34 (33%) in women. The mean age of these 
individuals was 58.7 + 188 years with a range of 14 to 94 
years. Ninety-eight samples were exudates and five transu- 
dates (Table I). 
The diagnosis of the 27 cases of TB by conventional 
methods revealed smear/culture values in pleural fluid of 
11.1%/33.3%, and of 33.3%/51.8 in blind tissue biopsy, as 
well as the presence of granulomas in tissue biopsy in 
85.1% of cases. The total diagnostic yield of all studies was 
96.2% (Table 2). 
The mean values of ADA,, ADAi and ADAi/ADA, 
ratio in pleural fluid showed very significant differences 
between the TB and non-TB group (Pi 0.00001); TB: 
ADA, 54.7i23.5 IU and ADAi/ADA, ratio 0.271tO.08 
TABLE 1. Aetiology of pleural effusions 
Diagnosis I2 % 
Tuberculosis 
Carcinomas 
Parapneumonic 
Paramalignant 
Empyema 
Lymphoma 
Trasudates 
Pulmonary embolism 
Traumatic 
Mesothelioma 
Idiopathic 
27 
23 
18 
10 
8 
6 
5 
2 
2 
26.2 
22.3 
17.4 
9.7 
7.7 
5.8 
4.8 
1.9 
1.9 
0.9 
0.9 
TABLE 2. Diagnostic yield of pleural TB by conventional 
methods 
Pleural fluid Pleural biopsy 
Smear (+) 
Culture (+) 
Granulomas (+) 
3/27 11.1% 9/27 33.3% 
9127 33.3% 14127 518% 
23/27 85.1% 
Smear(T)+cuiture(+) 
+granuloma 
26127 96.2% 
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TABLE 3. Mean of ADA,,, ADAi and ADAi/ADA, in TB 
and non-TB group 
TB Non-TB P 
ADAp (IU) 54.7k23.5 l&3+43.2 < 0~00001 
ADA1 (IU) 14.516.4 12.2 f 16.5 < 0.0003 
ADAl/ADAp 0.27 + 0.08 0.64+0.14 < 0~00001 
TABLE 4. Yield of ADA, with respect to ADAi/ADA, ratio 
in pleural effusion in the diagnosis of pleural tuberculosis 
ADA, ADAi/ADA, 
Sensitivity 88.8% 100% 
Specificity 92.1% 98.6% 
Positive predictive value 80% 96.4% 
Negative predictive value 95.8% 100% 
Accuracy 91.2% 99% 
True positive 24 27 
True negative 70 75 
False positive 6 1 
False negative 3 0 
Cut-off value for TB >40 IU < 0.42 ratio 
TABLE 5. Correlation of ADA, level in pleural effusion with 
lymphocite and monocyte cell count in patients with TB 
effusions 
ADA, ADAi ADA2 
TBC Lymphocytes 0.036 0.492 0.483 
P=O.835 P<O.O2 P<O.O2 
Monocytes 0.796 0.513 0.453 
P<O.OOl P<O.Ol P=O.O3 
and non-TB: ADA, 18.3 + 43.2 IU and ADAi/ADA, ratio 
0.64kO.14 (Table 3). 
The analysis to determine the discriminating value of 
these parameters to differentiate between the TB and non- 
TB group (Table 4), shows that the ADAi/ADA, ratio is 
the most efficacious diagnostic parameter (99.02%), since it 
identifies TB (with a cut-off level of < 0.42) with a 
sensitivity of loo%, a specificity of 98.6%, a PPV of 96.4% 
and a NPV of 100% and corrects all cases of false positive 
ADA, (three empyemas and two lymphomas) except for a 
pleural melanoma, and bears no false negatives (Fig. 1). 
The correlation analysis between ADA, and the number 
of lymphocytes and monocytes in pleural fluid was carried 
out in the TB group (Table 5). The findings showed a close 
correlation only with monocytes 0.796 (P<O.OOl) and not 
with lymphocytes 0.036 (P= ns.). 
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FIG. 1. Distribution of the ADAi/ADAp ratio. 
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Discussion 
Pleural tuberculosis (TB) is a frequent aetiology in the 
majority of the studies of pleural efussions (> 15%) (l), and 
its rising incidence is concommitant of the high prevalence 
of tuberculosis associated with HIV (29). 
Conventional diagnosis of TB is often determined by the 
presence of necrotic caseous granulomas in pleural biopsy 
tissue (> 85%) since the identification of mycobacteria by 
smear or culture in fluid/or tissue does not surpass a 60% 
yield (l-5,27,30,3 1). From the numerous parameters 
employed as alternative methods of diagnosis (bactec, 
PCR, lysozyme, ADA, tuberculoustearic acid, INF-y, IL- 
2, IL-6, 1-12, CD-8) (3-16) ADA and INF-y are the most 
useful. Both display similar yields in terms of sensitivity and 
specificity. However, in terms of cost and speed of 
diagnosis, ADA is the most suitable parameter (2 $U.S. 
and 20 min) (16,32-34). 
Levels of ADA, in pleural fluid > 40 IU can indicate 
pleural tuberculosis with sensitivity (Sl-100%) and speci- 
ficity (83-100%) (16,20). However, some groups use ADA, 
as a parameter for excluding rather than confirming pleural 
tuberculosis, due to the incidence of false positives, 
especially in empyemas, lymphomas and malignant diseases 
(16,20). The disparity in results not only arises from the 
employment of different determining techniques (Giusti, 
Black-Berman) (28,35), but also, to a great extent, from the 
lack of association between the origin and significance of 
pleural ADA in the studies. 
Pleural activity of ADA is expressed by the participation 
of two principal isoenzymes, ADAi and ADA2, which 
exhibit different optimum pHs, Michaelis constants (K,) 
and substrate specificities (21;24,25). ADAi has a low K, 
value, an optimum pH in the range of 7-7.5 and shows 
approximately equal affinity for adenosine and 2-deoxi 
adenosine. It is present in all tissues and has greatest 
activity in lymphocytes and monocytes. ADA2, on the other 
hand, has an optimum pH of approximately 6.5, has a high 
K, value, shows poor affinity for 2-deoxiadenosine and 
occurs only in monocytes (21,25). Stimulation of monocytes 
by the phagocytosis of micro-organisms (mycobacterium 
tuberculosis) allows the release of ADA1, which will 
consequently reduce the ADAr/ADA, ratio (21). Since both 
ADAi and ADA2 can present high values due to a greater 
activity of both cellular components it can be deduced that it 
is the proportional value of ADAl or ADA2 with respect to 
pleural ADA, and not the absolute values that are relevant 
for an adequate interpretation of results (21-25). 
The discriminating capacity of pleural ADA, to identify 
pleural tuberculosis reports high levels of sensitivity (81- 
100%) and specificity (83-100%). The false positive cases 
are mainly accounted for in the literature as being due to 
empyemas, lymphomas, malignant diseases and other aetio- 
logies such as parapneumonic or collagen vascular disease, 
which have a much lower incidence. The present study 
shows similar results to the above (sensitivity 8X.8%, 
specificity 92.1%, positive predictive value 80%, negative 
predictive value 95.8% and accuracy 91.2%), with six false 
positives cases (three empyemas, two lymphomas and one 
melanoma) 
The correction of false positives through the propor- 
tional determination of isoenzymes with respect to total 
ADA, activity in pleural fluid (ADAi/ADA,) is the most 
significant contribution of the present study. 
To date, the cellular origin of pleural ADA has remained 
uncertain and the majority of groups have suggested it is 
related to the increased cellular activity of lymphocytes 
(31,36-38). This hypothesis is not corroborated in our 
study, since the levels of total pleural ADA, correlate with 
the lymphocytic and monocytic counts, whilst in the case of 
pleural tuberculosis correlation only appears to exist with 
the monocytic count. This finding confirms that the 
monocytes/macrophages could be responsible for the high 
levels of ADA in tuberculosis effusion, but only as a result 
of the release of the isoenzyme ADAP. In consequence, this 
could be why a proportion of ADAr/ADA, 5 0.42 is 
a good indicator of TB in our study, with an accuracy 
of 99%, a sensitivity of loo%, a specificity of 98.6%, a 
PPV of 96.4% and a NPV of lOO%, thus correcting 
all ADA, false positive diagnoses of empyemas and 
lymphomas as tuberculosis cases, except for a single 
melanoma. 
Our observations conclude that the ADA, level in pleural 
fluid is a good parameter for TB diagnosis. However, in 
cases of suspected false negative or positive ADA, levels 
(frequent in empyemas, lymphomas and malignant effu- 
sions) suggested by other criteria, we advocate confirmation 
by the more efficacious ADAi/ADA, ratio. 
Both tests constitute useful markers of tuberculous 
effusions because of their low cost, high diagnostic yields, 
simplicity of thoracentesis and rapid diagnosis, and should 
be incorporated in the routine study and diagnosis of 
pleural tuberculosis. 
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